Pfizer: Statement Of Investor Complaints For The Quarter Ended September 2022 | Value Research

Pfizer: Statement Of Investor Complaints For The Quarter Ended September 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
036360
Name of the Signatory :- Prajeet Nair
Designation :- Company Secretary and Compliance Officer


Other Categories